title: Bevacizumab: the phoenix of breast oncology?
authors.affiliation: Department of Medical Oncology, Gustave Roussy, Villejuif, France; INSERM Unit U981 and Université Paris Sud, Faculté de Medecine Kremlin Bicetre, Kremlin Bicetre, France. Electronic address: fandre@igr.fr.
authors.forename: Fabrice
authors.initials: F
authors.lastname: Andre
authors.affiliation: Department of Medical Oncology, Gustave Roussy, Villejuif, France.
authors.forename: Elise
authors.initials: E
authors.lastname: Deluche
authors.affiliation: Department of Medical Oncology, Institut Bergonie, Bordeaux, France.
authors.forename: Herve
authors.initials: H
authors.lastname: Bonnefoi
mesh_terms: D061067:Antibodies, Monoclonal, Humanized / Q000008:administration & dosage*; D000971:Antineoplastic Combined Chemotherapy Protocols; D001943:Breast Neoplasms / Q000188:drug therapy*; D005260:Female; D006801:Humans; D043823:Taxoids / Q000008:administration & dosage*
chemical_list: D061067:Antibodies, Monoclonal, Humanized; D043823:Taxoids